Actively Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Led by Mirador Therapeutics, Inc. · Updated on 2026-03-12
140
Participants Needed
66
Research Sites
136 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
CONDITIONS
Official Title
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Crohn's Disease confirmed by endoscopy and histopathology
- Moderately to severely active Crohn's Disease defined by Clinical Disease Activity Index and Simple Endoscopic Score
- Meets drug stabilization requirements for Crohn's Disease
- Diagnosis of Ulcerative Colitis confirmed by endoscopy and histopathology
- Moderately to severely active Ulcerative Colitis defined by 3-component MMCS
- Meets drug stabilization requirements for Ulcerative Colitis
You will not qualify if you...
- Diagnosis of indeterminate colitis
- Suspected or diagnosed intra-abdominal or perianal abscess at screening
- Previous small bowel resection with combined length over 100 cm or previous colonic resection of more than 2 segments
- Crohn's Disease isolated to stomach, duodenum, jejunum, or perianal region without colon or ileal involvement
- Current or recent (within 6 months) fulminant colitis, toxic megacolon, or bowel perforation
- Current stoma or planned colostomy or ileostomy
- Received intravenous corticosteroids within 14 days prior to screening or during screening
- Previous total proctocolectomy or subtotal colectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 66 locations
1
Mirador Therapeutics Selected Site
Birmingham, Alabama, United States, 35235
Actively Recruiting
2
Mirador Therapeutics Selected Site
Scottsdale, Arizona, United States, 85258
Actively Recruiting
3
Mirador Therapeutics Selected Site
Sun City, Arizona, United States, 85351
Actively Recruiting
4
Mirador Therapeutics Selected Site
Little Rock, Arkansas, United States, 72205
Actively Recruiting
5
Mirador Therapeutics Selected Site
Little Rock, Arkansas, United States, 72211
Actively Recruiting
6
Mirador Therapeutics Selected Site
Colorado Springs, Colorado, United States, 80921
Actively Recruiting
7
Mirador Therapeutics Selected Site
Littleton, Colorado, United States, 80120
Actively Recruiting
8
Mirador Therapeutics Selected Site
Miami, Florida, United States, 33134
Actively Recruiting
9
Mirador Therapeutics Selected Site
Miami, Florida, United States, 33165
Actively Recruiting
10
Mirador Therapeutics Selected Site
Miami, Florida, United States, 33176
Actively Recruiting
11
Mirador Therapeutics Selected Site
Orlando, Florida, United States, 32825
Actively Recruiting
12
Mirador Therapeutics Selected Site
Palmetto Bay, Florida, United States, 33176
Actively Recruiting
13
Mirador Therapeutics Selected Site
Pensacola, Florida, United States, 32504
Actively Recruiting
14
Mirador Therapeutics Selected Site
Atlanta, Georgia, United States, 30342
Actively Recruiting
15
Mirador Therapeutics Selected Site
Snellville, Georgia, United States, 30078
Actively Recruiting
16
Mirador Therapeutics Selected Site
Glenview, Illinois, United States, 60026
Actively Recruiting
17
Mirador Therapeutics Selected Site
Gurnee, Illinois, United States, 60031
Actively Recruiting
18
Mirador Therapeutics Selected Site
Lafayette, Louisiana, United States, 70503
Actively Recruiting
19
Mirador Therapeutics Selected Site
Marrero, Louisiana, United States, 70072
Actively Recruiting
20
Mirador Therapeutics Selected Site
Shreveport, Louisiana, United States, 71105
Actively Recruiting
21
Mirador Therapeutics Selected Site
Ypsilanti, Michigan, United States, 48197
Actively Recruiting
22
Mirador Therapeutics Selected Site
Bridgeton, Missouri, United States, 63044
Actively Recruiting
23
Mirador Therapeutics Selected Site
Kansas City, Missouri, United States, 64114
Actively Recruiting
24
Mirador Therapeutics Selected Site
Liberty, Missouri, United States, 64068
Actively Recruiting
25
Mirador Therapeutics Selected Site
Las Vegas, Nevada, United States, 89128
Actively Recruiting
26
Mirador Therapeutics Selected Site
New York, New York, United States, 10016
Actively Recruiting
27
Mirador Therapeutics Selected Site
Rochester, New York, United States, 14618
Actively Recruiting
28
Mirador Therapeutics Selected Site
High Point, North Carolina, United States, 27262
Actively Recruiting
29
Mirador Therapeutics Selected Site
Raleigh, North Carolina, United States, 27612
Actively Recruiting
30
Mirador Therapeutics Selected Site
Cincinnati, Ohio, United States, 45219
Actively Recruiting
31
Mirador Therapeutics Selected Site
Liberty Township, Ohio, United States, 45044
Actively Recruiting
32
Mirador Therapeutics Selected Site
Providence, Rhode Island, United States, 02904
Actively Recruiting
33
Mirador Therapeutics Selected Site
Greenville, South Carolina, United States, 29607
Actively Recruiting
34
Mirador Therapeutics Selected Site
Cordova, Tennessee, United States, 38018
Actively Recruiting
35
Mirador Therapeutics Selected Site
Dallas, Texas, United States, 75230
Actively Recruiting
36
Mirador Therapeutics Selected Site
Garland, Texas, United States, 75044
Actively Recruiting
37
Mirador Therapeutics Selected Site
Georgetown, Texas, United States, 78628
Actively Recruiting
38
Mirador Therapeutics Selected Site
Houston, Texas, United States, 77090
Actively Recruiting
39
Mirador Therapeutics Selected Site
Lubbock, Texas, United States, 79424
Actively Recruiting
40
Mirador Therapeutics Selected Site
Southlake, Texas, United States, 76092
Actively Recruiting
41
Mirador Therapeutics Selected Site
Tyler, Texas, United States, 75701
Actively Recruiting
42
Mirador Therapeutics Selected Site
Webster, Texas, United States, 77598
Actively Recruiting
43
Mirador Therapeutics Selected Site
Bellevue, Washington, United States, 98004
Actively Recruiting
44
Mirador Therapeutics Selected Site
Silverdale, Washington, United States, 98383
Actively Recruiting
45
Mirador Therapeutics Selected Site
Tacoma, Washington, United States, 98405
Actively Recruiting
46
Mirador Therapeutics Selected Site
Milwaukee, Wisconsin, United States, 53215
Actively Recruiting
47
Mirador Therapeutics Selected Site
Toronto, Canada
Actively Recruiting
48
Mirador Therapeutics Selected Site
Kutaisi, Georgia
Actively Recruiting
49
Mirador Therapeutics Selected Site
Marneuli, Georgia
Actively Recruiting
50
Mirador Therapeutics Selected Site
Tbilisi, Georgia, 0102
Actively Recruiting
51
Mirador Therapeutics Selected Site
Tbilisi, Georgia, 0144
Actively Recruiting
52
Mirador Therapeutics Selected Site
Tbilisi, Georgia, 0159
Actively Recruiting
53
Mirador Therapeutics Selected Site
Tbilisi, Georgia, 0178
Actively Recruiting
54
Mirador Therapeutics Selected Site
Tbilisi, Georgia, 0180
Actively Recruiting
55
Mirador Therapeutics Selected Site
Tbilisi, Georgia, 4600
Actively Recruiting
56
Mirador Therapeutics Selected Site
Chisinau, Moldova
Actively Recruiting
57
Mirador Therapeutics Selected Site
Chisinau, Moldova
Actively Recruiting
58
Mirador Therapeutics Selected Site
Ivano-Frankivsk, Ukraine
Actively Recruiting
59
Mirador Therapeutics Selected Site
Kyiv, Ukraine, 02002
Actively Recruiting
60
Mirador Therapeutics Selected Site
Kyiv, Ukraine, 02091
Actively Recruiting
61
Mirador Therapeutics Selected Site
Kyiv, Ukraine, 03037
Actively Recruiting
62
Mirador Therapeutics Selected Site
Kyiv, Ukraine
Actively Recruiting
63
Mirador Therapeutics Selected Site
Lutsk, Ukraine
Actively Recruiting
64
Mirador Therapeutics Selected Site
Lviv, Ukraine
Actively Recruiting
65
Mirador Therapeutics Selected Site
Poltava, Ukraine
Actively Recruiting
66
Mirador Therapeutics Selected Site
Vinnytsia, Ukraine
Actively Recruiting
Research Team
A
ASCEND-IBD Trial Center
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here